{"id":17861,"date":"2022-12-04T13:12:20","date_gmt":"2022-12-04T13:12:20","guid":{"rendered":"http:\/\/cvx.vc\/?p=17861"},"modified":"2023-11-28T08:18:46","modified_gmt":"2023-11-28T08:18:46","slug":"biotech-company-raises-an-eight-figure-amount","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/","title":{"rendered":"BioTech company raises an eight-figure amount"},"content":{"rendered":"\n

The privately owned Danish biotech company Union Therapeutics has completed a capital injection of DKK 62 million. <\/p>\n\n\n\n

The money comes from a group of existing and new investors through the issue of new shares. According to Union, the income makes it possible to speed up the development of the company’s clinical pipeline with the two lead molecules orismilast and niclosamide.<\/p>\n\n\n\n

Orismilast is currently in two different phases 2 studies, and the US FDA has granted so-called fast-track status to the drug candidate, which can potentially treat psoriasis, atopic eczema, and the chronic skin disorder hidradenitis (HS). <\/p>\n\n\n\n

“Union is approaching a new phase in development with expected data from ongoing clinical trials in four different indications within the next 12 months. Within each of these indications, we have the potential to address the significant unmet need for millions of patients worldwide, and we appreciate the continued support from our investors to realize this potential,” says CEO Kim Kj\u00f8ller in the press release.<\/p>\n\n\n\n

Read the full article at KapWatch right\u00a0here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company’s two leading products, orismilast and niclosamide.<\/p>\n","protected":false},"author":25,"featured_media":17862,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18,20],"tags":[],"yoast_head":"\nBioTech company raises an eight-figure amount | CVX Ventures<\/title>\n<meta name=\"description\" content=\"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioTech company raises an eight-figure amount\" \/>\n<meta property=\"og:description\" content=\"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-04T13:12:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-28T08:18:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"BioTech company raises an eight-figure amount\",\"datePublished\":\"2022-12-04T13:12:20+00:00\",\"dateModified\":\"2023-11-28T08:18:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\"},\"wordCount\":173,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp\",\"articleSection\":[\"Blogindl\u00e6g\",\"Investments\"],\"inLanguage\":\"da-DK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\",\"url\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\",\"name\":\"BioTech company raises an eight-figure amount | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp\",\"datePublished\":\"2022-12-04T13:12:20+00:00\",\"dateModified\":\"2023-11-28T08:18:46+00:00\",\"description\":\"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp\",\"width\":960,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioTech company raises an eight-figure amount\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BioTech company raises an eight-figure amount | CVX Ventures","description":"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/","og_locale":"da_DK","og_type":"article","og_title":"BioTech company raises an eight-figure amount","og_description":"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.","og_url":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2022-12-04T13:12:20+00:00","article_modified_time":"2023-11-28T08:18:46+00:00","og_image":[{"width":960,"height":540,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp","type":"image\/webp"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"BioTech company raises an eight-figure amount","datePublished":"2022-12-04T13:12:20+00:00","dateModified":"2023-11-28T08:18:46+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/"},"wordCount":173,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp","articleSection":["Blogindl\u00e6g","Investments"],"inLanguage":"da-DK"},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/","url":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/","name":"BioTech company raises an eight-figure amount | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp","datePublished":"2022-12-04T13:12:20+00:00","dateModified":"2023-11-28T08:18:46+00:00","description":"Union Therapeutics has secured capital from new and existing investors. The money will be used to speed up the development of the company's two leading products, orismilast and niclosamide.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/12\/Title-mangler.webp","width":960,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/investments\/biotech-company-raises-an-eight-figure-amount\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"BioTech company raises an eight-figure amount"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/17861"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=17861"}],"version-history":[{"count":1,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/17861\/revisions"}],"predecessor-version":[{"id":26694,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/17861\/revisions\/26694"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/17862"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=17861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=17861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=17861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}